Transpek Industry FY26 Profit Falls; Q4 EBITDA Margin Contracts to 11.96%

2 min read     Updated on 26 May 2026, 11:41 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Transpek Industry reported a decline in FY26 consolidated net profit to ₹4,564.54 lakh from ₹4,873.70 lakh, with revenue from operations falling to ₹6,211.99 crore from ₹6,498.53 crore. Q4 performance was notably weak, with EBITDA contracting to ₹177M from ₹322M YoY and EBITDA margin narrowing to 11.96% from 19.50%. The Board recommended a ₹20 per share dividend and fixed the AGM for September 15, 2026.

powered bylight_fuzz_icon
41351805

*this image is generated using AI for illustrative purposes only.

Transpek Industry Limited reported a decline in consolidated net profit for the financial year ended March 31, 2026, while its Board of Directors recommended a dividend of ₹20 per equity share. The company recorded a consolidated net profit of ₹4,564.54 lakh for FY26, compared to ₹4,873.70 lakh in the previous year. Revenue from operations for the year stood at ₹6,211.99 crore, down from ₹6,498.53 crore in FY25. The Board approved the audited financial results for the quarter and year ended March 31, 2026, during its meeting on May 26, 2026.

The statutory auditor, Bansi S. Mehta & Co., provided an unmodified opinion on the standalone and consolidated financial results, confirming compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditors confirmed that the statements present a true and fair view in conformity with Indian Accounting Standards. The consolidated financial results incorporate data from Transpek Creative Chemistry Private Limited, a wholly owned subsidiary.

Q4 Performance: Profitability Under Pressure

For the quarter ended March 31, 2026, Transpek Industry's operational profitability deteriorated sharply on a year-on-year basis. Q4 EBITDA declined to ₹177M from ₹322M in the same period last year, while the EBITDA margin contracted significantly to 11.96% from 19.50% YoY. On a standalone basis, Q4 net profit fell to ₹66M from ₹193M YoY, and Q4 revenue came in at ₹1.5B compared to ₹1.65B in the corresponding period. On a consolidated basis, the company reported a net profit of ₹658.03 lakh for the quarter, a decrease from ₹1,925.13 lakh in the same period last year, with consolidated revenue at ₹1,482.15 crore versus ₹1,652.57 crore in Q4FY25. Total expenses for the quarter amounted to ₹1,436.55 crore.

The following table summarises the key Q4 metrics on a year-on-year basis:

Metric: Q4 FY26 Q4 FY25
EBITDA: ₹177M ₹322M
EBITDA Margin: 11.96% 19.50%
Standalone Net Profit: ₹66M ₹193M
Revenue: ₹1.5B ₹1.65B
Consolidated Net Profit: ₹658.03 lakh ₹1,925.13 lakh
Consolidated Revenue: ₹1,482.15 crore ₹1,652.57 crore

Dividend and AGM Details

The Board has fixed the Annual General Meeting for September 15, 2026, at 3.00 p.m. via video conferencing. The recommended dividend of ₹20 per share, amounting to 200% of the face value of ₹10, is subject to shareholder approval at the AGM. If approved, the dividend will be paid within 30 days of the declaration. The company's earnings per share (EPS) for the year stood at ₹81.72 on a consolidated basis, down from ₹87.25 in the previous year. The trading window, which had been closed since April 1, 2026, is set to reopen on May 28, 2026.

Financial Summary for FY26

The table below presents the key annual financial metrics for FY26 on both a standalone and consolidated basis:

Metric: Standalone FY26 (₹ in Lakhs) Consolidated FY26 (₹ in Lakhs)
Revenue from Operations: 62,119.90 62,119.90
Total Income: 64,570.34 64,570.34
Total Expenses: 58,450.62 58,450.89
Net Profit for the period: 4,564.81 4,564.54
Earnings Per Share (Basic): 81.73 81.72

Historical Stock Returns for Transpek Industry

1 Day5 Days1 Month6 Months1 Year5 Years
-10.42%-12.41%-7.14%-5.91%-5.91%-5.91%

What specific factors led to the sharp decline in Q4 EBITDA margins, and are these pressures expected to persist into the next financial year?

How will the company balance the recommended dividend payout with the observed decline in annual net profit and earnings per share?

What strategic initiatives does Transpek Industry plan to implement to reverse the trend of falling revenue and operational profitability?

Transpek Industry Board Meeting Scheduled on May 26, 2026 to Approve Q4FY26 Audited Financial Results

1 min read     Updated on 18 May 2026, 10:54 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Transpek Industry Limited has notified BSE Limited of a board meeting on May 26, 2026, at 2:00 p.m., to consider and approve audited standalone and consolidated financial results for Q4 and the year ended March 31, 2026. The meeting is being held pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015. The company will also communicate details of any dividend recommendation after the board meeting concludes. The trading window, closed since April 1, 2026, will re-open 48 hours after the declaration of results.

powered bylight_fuzz_icon
40627469

*this image is generated using AI for illustrative purposes only.

Transpek Industry Limited has informed BSE Limited of a board meeting scheduled for Tuesday, May 26, 2026, at 2:00 p.m., to be conducted through audio-visual means. The notice, issued pursuant to Regulation 29(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was submitted on May 18, 2026, and signed by Company Secretary and Compliance Officer Alak D. Vyas.

Board Meeting Agenda

The primary agenda of the board meeting is to consider and approve the audited standalone and consolidated financial results for the fourth quarter and year ended March 31, 2026, along with the Auditors' Report. The key details of the scheduled meeting are outlined below:

Parameter: Details
Meeting Date: Tuesday, May 26, 2026
Meeting Time: 2:00 p.m.
Mode: Audio-Visual Means
Results Period: Fourth Quarter and Year Ended March 31, 2026
Results Type: Audited Standalone and Consolidated
Regulatory Reference: Regulation 29(2) of SEBI (LODR) Regulations, 2015

Dividend and Exchange Communication

The company has stated that it will intimate BSE Limited of the audited standalone and consolidated financial results, along with details of any dividend recommendation by the board, after the conclusion of the board meeting on May 26, 2026.

Trading Window Closure

In accordance with the company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their immediate relatives, the trading window for dealing in securities of the company has been closed since April 1, 2026. The trading window will re-open 48 hours after the declaration of the financial results on May 26, 2026.

The filing was submitted from the company's registered office located at 4th Floor, Lilleria 1038, Gotri - Sevasi Road, Vadodara - 390021, Gujarat, India, with works situated at At. & Post: Ekalbara, Taluka: Padra, Dist.: Vadodara - 391 440, Gujarat, India.

Historical Stock Returns for Transpek Industry

1 Day5 Days1 Month6 Months1 Year5 Years
-10.42%-12.41%-7.14%-5.91%-5.91%-5.91%

Will Transpek Industry recommend a dividend for FY2026, and how does its dividend history compare to industry peers in the specialty chemicals sector?

How have Transpek Industry's revenue and profitability trends evolved over the past few quarters, and what growth trajectory might the FY2026 annual results reveal?

What are the key business segments driving Transpek Industry's performance, and could any strategic expansions or capacity additions be announced alongside the Q4 results?

More News on Transpek Industry

1 Year Returns:-5.91%